Skip to main content
AVLS Congress and UIP 2023 World Congress Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Stream Session
Live Stream Session
Ticketed Event
Ticketed Event
Invitation Only
Invitation Only
Translation
Translation
Recorded Content
Recorded Content
CME
CME
Non-CME
Non-CME
Back
Watch Recording

General Session
Livestream

Keynote - Debate Sessions 3.0

Wednesday, September 20, 2023
2:30 PM – 5:00 PM US EDT
Location: Grand Ballroom B
CE: 2.5

Live Stream Session Translation Recorded Content CME

    Chair(s)

  • Alun Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FLSW, FACPh

    Professor of Vascular Surgery
    Section of Vascular Surgery, Imperial College London
    Imperial College
    London, England, United Kingdom

    Disclosure(s):

    The forementioned Program Planner, Faculty, Author, Moderator, or Speaker, has declared for this educational activity, having no relevant financial relationship(s) with ineligible companies to disclose. or AVLS has reviewed / mitigated there are no relevant financial relationships with ineligible companies.

    • Co-Chair(s)

  • John Blebea, MD, MBA

    Clinical Professor of Surgery
    Central Michigan University
    Central Michigan University
    Saginaw, MI, United States

    Disclosure(s):

    The forementioned Program Planner, Faculty, Author, Moderator, or Speaker, has declared for this educational activity, having no relevant financial relationship(s) with ineligible companies to disclose. or AVLS has reviewed / mitigated there are no relevant financial relationships with ineligible companies.

  • Kathleen Gibson, MD, FACS, FAVLS

    Congress President
    Lake Washington Vascular Surgeons
    Bellevue, Washington, United States

    Disclosure(s): Boston Scientific: Consultant/Advisory Board, Other Research Support, Speaker/Honoraria; Gore: Consultant/Advisory Board, Research Grant; Janssen: Speaker/Honoraria; Koya: Consultant/Advisory Board; Medtronic: Consultant/Advisory Board, Other Research Support, Research Grant, Speaker/Honoraria; Philips: Consultant/Advisory Board, Speaker/Honoraria

  • Fedor Lurie, MD, PhD (he/him/his)

    UIP Research Chair
    Jobst Vascular Institute
    University of Michigan
    Toledo, Ohio, United States

    Disclosure(s): Sigvar: Speaker/Honoraria

  • MM

    Mark Meissner, MD

    Peter Gloviczki Professor of Venous and Lymphatic Disorders
    University of Washington
    University of Washington School of Medicine
    Seattle, WA, United States

    Disclosure(s):

    The forementioned Program Planner, Faculty, Author, Moderator, or Speaker, has declared for this educational activity, having no relevant financial relationship(s) with ineligible companies to disclose. or AVLS has reviewed / mitigated there are no relevant financial relationships with ineligible companies.

Keynote - Debate Sessions

Learning Objectives:

  • To increase our understanding of venous and lymphatic diseases through debates on the key issues.
  • To learn different points of view on key clinical aspects of CVD.
  • To increase our understanding of venous and lymphatic diseases through debates on the key issues.

Presentations:

  • 2:30 PM – 5:00 PM US EDT
    Keynote - Debate Sessions 3.0

    Chair: Alun H. Davies, MA DM DSc FRCS FACPh – Imperial College London

    Co-Chair: John Blebea, MD, MBA – Central Michigan University

    Co-Chair: Kathleen Gibson, MD, FACS, FAVLS – Lake Washington Vascular Surgeons

    Co-Chair: Fedor Lurie, MD, PhD (he/him/his) – Jobst Vascular Institute

    Co-Chair: Mark Meissner, MD – University of Washington

  • 2:31 PM – 2:35 PM US EDT
    Welcome

    Chair: Alun H. Davies, MA DM DSc FRCS FACPh – Imperial College London

  • 2:35 PM – 3:00 PM US EDT
    Debate 3.1: Thrombolysis Is Dead, Long Live Thrombectomy

    Debate Moderator: Alun H. Davies, MA DM DSc FRCS FACPh – Imperial College London

  • 2:36 PM – 3:00 PM US EDT
    Against: Thrombolysis Is Dead, Long Live Thrombectomy

    Debater - Con: Kush R. Desai, MD, FSIR – Northwestern University

  • 2:36 PM – 3:00 PM US EDT
    Pro: Thrombolysis Is Dead, Long Live Thrombectomy

    Debater - Pro: David Dexter, MD – Eastern Virginia Medical School

  • 2:55 PM – 3:20 PM US EDT
    Lymphedema- lipedema Syndrome: 2 Separate Disorders or 2 Sides of One Coin?

    Faculty: Robert J. Damstra, MD PhD (he/him/his) – Expert center for lymph-vascular medicine (ECL) Nij Smellinghe hospital

  • 3:20 PM – 3:40 PM US EDT
    Debate 3.2: Should We Spare the Saphenous Vein? (CHIVA/ASVAL Is No Better Than Non-saphenous Sparing Techniques)

    Debate Moderator: Alun H. Davies, MA DM DSc FRCS FACPh – Imperial College London

  • 3:21 PM – 3:40 PM US EDT
    Against: Should We Spare the Saphenous Vein? (CHIVA/ASVAL Is No Better Than Non-saphenous Sparing Techniques)

    Debater - Con: Marianne G. De Maeseneer, MD PhD (she/her/hers) – Department of Dermatology, Erasmus Medical Centre, Rotterdam, Netherlands

  • 3:21 PM – 3:40 PM US EDT
    Pro: Should We Spare the Saphenous Vein? (is CHIVA/ASVAL Is No Better Than Non-saphenous Sparing Techniques)

    Debater - Pro: Erika Mendoza, MD, PhD (she/her/hers) – Venenpraxis Wunstorf

  • 3:40 PM – 4:00 PM US EDT
    Where Do We Go from Here? Future Research in Venous and Lymphatic Medicine

    Faculty: Sarah Onida, BSc PhD FRCSVasc – Imperial College London

  • 4:00 PM – 4:20 PM US EDT
    Deep Venous Valve Repair Coming of Age

    Faculty: Jorge Ulloa

  • 4:20 PM – 5:00 PM US EDT
    Keynote Address: Leadership in Crisis with Lt. General Karen Gibson (ret.)

    Keynote Speaker: Karen Gibson

    Moderator: Kathleen Gibson, MD, FACS, FAVLS – Lake Washington Vascular Surgeons